English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
proteinase inhibitor/neoplasms
The link is saved to the clipboard
15 results
Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor
Only registered users can translate articles
Log In/Sign up
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a 35 U.S.C. .sctn.371 National Phase Entry Application from PCT/DE01/01510, filed Apr. 18, 2001 and designating the United States. This application further claims foreign priority to German application DE 100 20 125.3, filed Apr. 18,
4-substitued-3-[1 or 2 amino acid residue]-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF INVENTION
Cysteine proteinases containing a highly reactive cysteine residue with a free thiol group at the active site have been known as playing important role in certain conditions distinguished by aberrant protein turnover such as: muscular dystrophy (Am. J. Pathol. 1986, 122,
Prostate specific antigen (PSA)-proteinase inhibitor complexes
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The prostate specific antigen (PSA) was first purified from prostatic tissue (Wang et al. Invest Urol 1979), but the same protein was almost simultaneously and independently characterized in the seminal plasma (Hara et al. J Lab Clin Med 1989; Graves et al. N Engl J Med
CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer
Only registered users can translate articles
Log In/Sign up
STATEMENT REGARDING SEQUENCE LISTING
The Sequence Listing associated with this application is provided in text format in lieu of a paper copy, and is hereby incorporated by reference into the specification. The name of the text file containing the Sequence Listing is
Therapeutic use for ALPHA1 proteinase inhibitor in hematopoiesis
Only registered users can translate articles
Log In/Sign up
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 15, 2012, is named 86519CON.txt and is 11,216 bytes in size.
BACKGROUND OF THE
Therapeutic use for .alpha..sub.1 proteinase inhibitor in hematopoiesis
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Full length active .alpha..sub.1 proteinase inhibitor (.alpha..sub.1PI, .alpha..sub.1 antitripsin) is composed of 394 amino acids (aa) having a mass of approximately 55 kDa when fully glycosylated (Berninger, 1985). Hepatocytes are the primary source of .alpha..sub.1PI,
Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitors
Only registered users can translate articles
Log In/Sign up
The present invention relates to compounds that are inhibitors of cysteine proteinases, pharmaceutical compositions containing said compounds, and their use in therapy. More specifically, but not exclusively, the invention relates to compounds that are inhibitors of cathepsin K and related cysteine
Furo[3,2-B] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
Only registered users can translate articles
Log In/Sign up
The present invention relates to compounds that are inhibitors of cysteine proteinases, pharmaceutical compositions containing said compounds, and their use in therapy. More specifically, but not exclusively, the invention relates to compounds that are inhibitors of cathepsin K and related cysteine
Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
Only registered users can translate articles
Log In/Sign up
The present invention relates to compounds that are inhibitors of cysteine proteinases, pharmaceutical compositions containing said compounds, and their use in therapy. More specifically, but not exclusively, the invention relates to compounds that are inhibitors of cathepsin K and related cysteine
Assay of free and complexed prostate-specific antigen (PSA)
Only registered users can translate articles
Log In/Sign up
The present invention relates to an immunoassay of prostate-specific antigen (PSA), in which specific reagent materials (antibodies) are used that allow the measurement of free PSA as well as the PSA proteinase inhibitor complex.
It also relates to the use of free PSA and the PSA proteinase
3,4-Disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Cysteine proteinases containing a highly reactive cysteine residue with a free thiol group at the active site have been known as playing an important role in certain conditions distinguished by aberrant protein turnover such as: muscular dystrophy (Am. J. Pathol. 1986,
4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Cysteine proteinases containing a highly reactive cysteine residue with a free thiol group at the active site have been known as playing an important role in certain conditions distinguished by aberrant protein turnover such as: muscular dystrophy (Am. J. Pathol. 1986,
4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Cysteine proteinases containing a highly reactive cysteine residue with a free thiol group at the active site have been known as playing an important role in certain conditions distinguished by aberrant protein turnover such as: muscular dystrophy (Am. J. Pathol. 1986,
Assay of free and complexed prostate-specific antigen
Only registered users can translate articles
Log In/Sign up
The present invention relates to an immunoassay of prostate-specific antigen (PSA), in which specific reagent materials (antibodies) are used that allow the measurement of free PSA as well as the PSA proteinase inhibitor complex.
It also relates to the use of free PSA and the PSA proteinase
Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention relates to methods and compositions for the inhibition of cellular proliferation. More particularly, the present invention relates to the use of tissue factor pathway inhibitor proteins or peptides, and active fragments thereof, for inhibiting
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
